{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:25:10Z","timestamp":1760300710999,"version":"3.41.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Causality regarding adverse events following SARS-CoV-2 mRNA vaccine is undetermined for vasculitis. Herein, we report the case of an 80-year-old man who presented with a persistent high fever of 7 days' duration that began shortly after receiving a COVID-19 vaccination. There was also a complaint of persistent lower limb pain and walking difficulty on emergency transportation. FDG PET\/CT demonstrated extensive linear hypermetabolic foci along the vessels of both legs, including the hips, and the arms, supraclavicular area, chest wall, and temporal regions, suggesting systemic vasculitis. Subsequent temporal artery biopsy revealed arteritis, which is not typical of giant cell arteritis.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004115","type":"journal-article","created":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T19:34:53Z","timestamp":1645126493000},"page":"e403-e405","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Systemic Vasculitis Following SARS-CoV-2 mRNA Vaccination Demonstrated on FDG PET\/CT"],"prefix":"10.1097","volume":"47","author":[{"given":"Koya","family":"Nakatani","sequence":"first","affiliation":[{"name":"Diagnostic Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsuro","family":"Sakata","sequence":"additional","affiliation":[{"name":"Diagnostic Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Fujihara","sequence":"additional","affiliation":[{"name":"General Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Mizukawa","sequence":"additional","affiliation":[{"name":"Endocrinology and Rheumatology, Kurashiki Central Hospital, Kurashiki, Okayama, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Koyama","sequence":"additional","affiliation":[{"name":"Diagnostic Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1007\/s00259-018-3973-8","article-title":"FDG-PET\/CT(a) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET interest group (PIG), and endorsed by the ASNC","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11604-020-01059-4","article-title":"Large vessel vasculitis: imaging standards of (18)F-FDG PET\/CT","volume":"39","year":"2021","journal-title":"Jpn J Radiol"},{"journal-title":"Intern Med","article-title":"The \u201cant-farm\u201d\u2013like appearance of restricted lower limb vasculitis on fluorodeoxyglucose\u2013positron emission tomography: a case series [published online August 31, 2021]","year":"2021","key":"bib3-20250621"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s11239-020-02230-4","article-title":"COVID-19\u2013associated vasculitis and vasculopathy","volume":"50","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"bib5-20250621","first-page":"1","article-title":"Vasculitis and bursitis on [18F]FDG-PET\/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"490","DOI":"10.18502\/jovr.v16i3.9443","article-title":"COVID-19 recombinant mRNA vaccines and serious ocular inflammatory side effects: real or coincidence?","volume":"16","year":"2021","journal-title":"J Ophthalmic Vis Res"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/ijd.15623","article-title":"Leukocytoclastic vasculitis flare following the COVID-19 vaccine","volume":"60","year":"2021","journal-title":"Int J Dermatol"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/j.ajkd.2021.06.016","article-title":"ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine","volume":"78","year":"2021","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:03:49Z","timestamp":1750536229000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004115","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2022,2,16]]}}}